PortfoliosLab logo

Anixa Biosciences, Inc. (ANIX)

Equity · Currency in USD · Last updated Apr 1, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Anixa Biosciences, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $550 for a total return of roughly -94.50%. All prices are adjusted for splits and dividends.


0.00%500.00%1,000.00%1,500.00%2,000.00%NovemberDecember2023FebruaryMarch
-94.50%
2,332.13%
ANIX (Anixa Biosciences, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ANIX

Anixa Biosciences, Inc.

Return

Anixa Biosciences, Inc. had a return of 1.18% year-to-date (YTD) and 52.48% in the last 12 months. Over the past 10 years, Anixa Biosciences, Inc. had an annualized return of -1.53%, while the S&P 500 had an annualized return of 10.09%, indicating that Anixa Biosciences, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-2.71%3.51%
Year-To-Date1.18%7.03%
6 months-5.70%12.88%
1 year52.48%-10.71%
5 years (annualized)2.29%9.25%
10 years (annualized)-1.53%10.09%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20232.82%1.14%
202217.99%13.82%-10.00%-15.67%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Anixa Biosciences, Inc. Sharpe ratio is 0.65. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00NovemberDecember2023FebruaryMarch
0.65
-0.46
ANIX (Anixa Biosciences, Inc.)
Benchmark (^GSPC)

Dividend History


Anixa Biosciences, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-98.49%
-14.33%
ANIX (Anixa Biosciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Anixa Biosciences, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Anixa Biosciences, Inc. is 99.79%, recorded on Aug 15, 2017. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.79%Sep 11, 19857998Aug 15, 2017
-55.56%Oct 26, 1984112Apr 8, 1985108Sep 10, 1985220
-41.77%Dec 20, 1983112May 30, 1984103Oct 24, 1984215
-15.87%Oct 27, 19832Oct 28, 198310Nov 11, 198312
-7.44%Nov 23, 19832Nov 25, 19832Nov 29, 19834
-4.48%Oct 19, 19831Oct 19, 19832Oct 21, 19833
-3.67%Oct 12, 19831Oct 12, 19832Oct 14, 19833
-3.24%Dec 1, 19831Dec 1, 198310Dec 15, 198311

Volatility Chart

Current Anixa Biosciences, Inc. volatility is 72.48%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%NovemberDecember2023FebruaryMarch
72.48%
15.42%
ANIX (Anixa Biosciences, Inc.)
Benchmark (^GSPC)